Naslov
Vaccination in pediatric acquired inflammatory immune-mediated neuromuscular disorders

Autori
Barišić, Nina ; Turudić, Daniel ; Stemberger Marić, Lorna ; Tešović, Goran

Izvornik
European Journal of Paediatric Neurology (1090-3798) 36 (2022); 159-176

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Guillain-barre syndrome ; Bell's palsy ; Optic neuritis ; Myasthenia gravis ; Chronic inflammatory demyelinating polyneuropathy ; Immune-mediated inflammatory myopathy ; Vaccination ; Vaccines ; Vaccine safety ; Pediatric immune-mediated inflammatory neuromuscular disorders ; Immunosupressive treatment

Sažetak
Aim To analyse literature data on vaccine related induction, worsening of the disease and disease reccurrences as well as vaccine safety and efficacy among pediatric patients with acquired inflammatory immune-mediated neuromuscular disorders (NMD). Methods Medline, Pub Med and Scopus database search from 1975 to 2020 focused on pediatric age was conducted including peer reviews, meta analyses and epidemiological studies on vaccination and Guillain-Barré syndrome (GBS), Bell's palsy, optic neuritis (ON), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP) and immune-mediated inflammatory myopathy (IM). Results and conclusion s: There are no strong evidence supporting relationship between vaccination with different pediatric vaccines and development of first episodes or reccurrences of GBS, Bell's palsy, optic neuritis (ON), juvenile MG, CIDP, and IM. The vaccination and revaccination with inactivated vaccines is considered safe in children with medical history of GBS, Bell's palsy, ON, MG and IM. Caution when immunization against influenza, quadrivalent conjugated meningococcal vaccine (MCV4) and pneumococcal disease and avoiding tetanus toxoid immunization in CIDP patients is suggested. Patients with immune mediated acquired NMD should be vaccinated with live vaccines before the initiation of immunosupressive treatment. Immunosuppressed patients with low protective antibody titers should be considered for revaccination.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA